Antihypertensive Treatment in Masked Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 320 participants.
Also called NCT02893358
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 320 participants
- Sponsor
- Yan Li
- Registry
-
NCT02893358
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02893358. Randomized; double masking; primary purpose prevention. Start 2017-02-14 (actual); primary completion 2021-10-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Antihypertensive Treatment in Masked Hypertension
- Acronym
- ANTI-MASK
- Condition
- Masked Hypertension
- Intervention (Drug)
- Allisartan Isoproxil
- Intervention (Drug)
- Placebo
- Lead sponsor
- Yan Li
Record details
- Record id
cardio:ct-nct02893358- Content hash
7d9a6b221448e36239a713551167fd32ad7635ae2d7fe2a8782314bb1a5d0f7d